Biotech | March 21, 2022
Wockhardt and Serum Life Sciences UK partner to manufacture multiple vaccines in UK
The facility will produce 150 million vaccine doses per year
The facility will produce 150 million vaccine doses per year
The investment will accelerate the overall Sarclisa development program
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
The company will collaborate with U.S.-based colleagues to help life sciences companies improve commercial effectiveness
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
Subscribe To Our Newsletter & Stay Updated
